MedPath

A. Nattermann & Cie. GmbH

🇩🇪Germany
Ownership
Subsidiary
Employees
-
Market Cap
-
Website
http://www.sanofi.de/de/sanofi-in-deutschland/standorte

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

3

NMPA:2
PHILIPPINES:1

Drug Approvals

Ambroxol Hydrochloride Oral Solution

Product Name
盐酸氨溴索口服溶液
Approval Number
国药准字HJ20250024
Approval Date
Mar 11, 2025
NMPA

Ambroxol Hydrochloride Oral Solution

Product Name
盐酸氨溴索口服溶液
Approval Number
国药准字HJ20250025
Approval Date
Mar 11, 2025
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.